Lecanemab approval being pursued for Alzheimer’s Treatment
Japan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read MoreJapan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read More(By Jeannie Fuglesten Biniek, Nolan Sroczynski, Meredith Freed, and Tricia Neuman for Kaiser Family Foundation Published: Nov 16, 2022) Medicare
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS wants all traditional Medicare beneficiaries and most Medicaid beneficiaries in accountable care
Read More(Source – cms.gov) COVID-19 has exacerbated the nation’s struggle with mental health and substance use disorders (collectively called “behavioral health
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS awarded fewer Medicare Advantage plans with five-star ratings for 2023 than in
Read More(Source – www.cms.gov) The Biden-Harris Administration is announcing that Medicare Open Enrollment begins tomorrow — Saturday, October 15 — and
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage premiums will decrease for 2023, CMS said Sept. 29, continuing a
Read More(Source – www.cms.gov/newsroom) The Centers for Medicare & Medicaid Services (CMS) announced today that the Medicare Shared Savings Program, through
Read More